EQUASHIELD Analysis: $300M Raised
What is EQUASHIELD?
EQUASHIELD specializes in Closed System Transfer Devices (CSTDs) and pharmacy compounding automation solutions. Their innovative technology protects healthcare workers from hazardous drug exposure and contamination. This commitment enhances safety and efficiency in healthcare environments.
HQ Country
Port Washington, United States
Employees
201-500
Founded
2004
Industry
HealthTech, Medical Devices
Product Features & Capabilities
- Closed System Transfer Devices for drug preparation
- Syringe Units designed to prevent contamination
- Vial Adaptors for safe drug transfer
- Mundus Mini HD for automated compounding
- CellSHIELD for gene therapy manufacturing.
How much EQUASHIELD raised
Series D - $300 million
October 6, 2022Lead Investor: Nordic Capital
